Insider Trading History of Khuong Chau Quang


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Khuong Chau Quang since year 2005. The trader's CIK number is 1609405. At the time of the last reporting, Khuong Chau Quang was the Director of Nextcure, Inc. . (stock ticker symbol NXTC). See this page for all insider trading activities at Nextcure, Inc. .

Note that in the past Khuong Chau Quang also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Khuong Chau Quang since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2019-05-13 NXTC Nextcure, Inc. Buy 350,000 15.00 5,250,000
2019-03-07 INSP Inspire Medical Systems, Inc. Sale 68,218 55.01 3,752,672
2019-03-08 INSP Inspire Medical Systems, Inc. Sale 290,231 57.75 16,760,840
2018-12-11 INSP Inspire Medical Systems, Inc. Sale 614,772 37.60 23,115,427
2018-06-28 ARPO Aerpio Pharmaceuticals, Inc. Buy 777,500 3.85 2,993,375
2018-05-07 INSP Inspire Medical Systems, Inc. Buy 312,500 16.00 5,000,000
2017-03-15 NONE Aerpio Pharmaceuticals, Inc. Buy 762,995 5.00 3,814,975
2015-11-25 OTIC Otonomy, Inc. Sale 34,800 28.91 1,006,068
2015-11-27 OTIC Otonomy, Inc. Sale 29,000 28.97 840,130
2015-11-30 OTIC Otonomy, Inc. Sale 3,306 28.93 95,642
2015-11-24 OTIC Otonomy, Inc. Sale 36,100 28.75 1,037,875
2015-11-20 OTIC Otonomy, Inc. Sale 83,900 28.59 2,398,701
2015-11-23 OTIC Otonomy, Inc. Sale 80,800 28.45 2,298,760
2015-11-17 OTIC Otonomy, Inc. Sale 11,098 28.95 321,231
2015-11-19 OTIC Otonomy, Inc. Sale 127,300 28.60 3,640,780
2015-07-06 PIRS Pieris Pharmaceuticals, Inc. Buy 500,000 2.75 1,375,000
2014-08-18 OTIC Otonomy, Inc. Buy 171,875 16.00 2,750,000

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Khuong Chau Quang (Director of Nextcure, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.